BioSpace News Archive

Teaches Patient Management and Triage in a simulated Mass Casualty Incident caused by an explosion. [26-July-2019] RANCHO CUCAMONGA, Calif. , July 26, 2019 /PRNewswire/ -- Disaster Management Systems, Inc., the nation’s leading supplier of disaster preparedness solutions, today announced the availability of a new tabletop training kit designed to acquaint first respon

Ra Medical Systems, Inc. (NYSE: RMED) today announced the launch of Pharos, Optimized, the next generation of Pharos excimer lasers, designed to enhance physician and patient experience with faster treatments for psoriasis, vitiligo, and atopic dermatitis; extended peak performance; and a new ergonomic handpiece for operator comfort and greater treatment site visibility.

KBL Merger Corp. IV (NASDAQ: KBLM) (“KBLM”), a Special Purpose Acquisition Company (SPAC), announced today that it has executed a definitive business combination agreement for the merger of a wholly owned subsidiary of KBLM with CannBioRx Life Sciences Corp.

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2019 financial results before market open on Wednesday, August 7, 2019.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that they achieved 27% revenue growth and 79% EBITDA growth in the first half of 2019 over the same period in 2018.

Montrium, today announces that Orphazyme, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, has chosen to extend Montrium’s eTMF Connect and RegDocs Connect solutions with Quality Connect to empower end-to-end commercialization processes.

MiRus is pleased to announce recent FDA 510(k) clearance of the CYGNUS™ Anterior Cervical Plate System, the narrowest and thinnest cervical plate on the market.

The Lange Law Firm, PLLC has been retained to investigate the Florida Cyclospora outbreak.

In its first year deploying an enhanced fraud, waste and abuse (FWA) program, Prime Therapeutics LLC (Prime) achieved an overall savings for its health plan clients of $279 million.

Several families have retained The Lange Law Firm, PLLC to investigate the New York Cyclospora outbreak.